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Endothelin receptor type A
LH
MAPK
Oocytedormant in the diplotene stage of prophase I until the resumption of meiosis
characterized by germinal vesicle breakdown (GVBD) following the preovulatory gonadotropin stimulation.
Based on genome-wide analysis of peri-ovulatory DNA microarray to identify paracrine hormone-receptor
pairs, we found increases in ovarian transcripts for endothelin-1 and endothelin receptor type A (EDNRA) in
response to the preovulatory luteinizing hormone (LH)/human chorionic gonadotropin (hCG) stimulation.
Immunohistochemical analyses demonstrated localization of EDNRA in granulosa and cumulus cells. In
cultured preovulatory follicles, treatment with endothelin-1 promoted oocyte GVBD. The stimulatory effect
of endothelin-1 was blocked by cotreatment with antagonists for the type A, but not related type B, receptor.
The stimulatory effect of hCG on GVBD was partially blocked by the same antagonist. The endothelin-1
promotion of GVBD was found to be mediated by the MAPK/ERK pathway but not by the inhibitory G protein.
Studies using cumulus–oocyte complexes and denuded oocytes demonstrated that the endothelin-1 actions
are mediated by cumulus cells. Furthermore, intrabursal administration with endothelin-1 induced oocyte
GVBD in preovulatory follicles. Our ﬁndings demonstrate a paracrine role of endothelin-1 in the induction of
the resumption of meiosis and provide further understanding on the molecular mechanisms underlying the
nuclear maturation of oocytes induced by the preovulatory LH surge.
© 2008 Elsevier Inc. All rights reserved.Introduction
In mammalian developing follicles, primary oocytes enter
meiosis but are arrested at the diplotene stage of prophase I. The
oocytes stay in this dormant state for months and years until they
are about to be ovulated. In response to the preovulatory luteinizing
hormone (LH) increase, the large nucleus of the oocytes (called the
germinal vesicle, GV) in preovulatory follicles undergo GV break-
down (GVBD), followed by ﬁrst polar body extrusion. Although the
preovulatory surge of LH is the primary event responsible for the
induction of maturation of the oocyte, LH and its surrogate human
chorionic gonadotropin (hCG) do not act directly on the oocyte due
to the absence of functional LH receptors in germ cells. Instead,
actions of LH/hCG are mediated either by paracrine factors secreted
by LH-responsive somatic cells (theca and mature granulosa cells)
or by the transport of cellular messengers from granulosa/cumulusa 010-8543, Japan. Fax: +81 18
amura).
l rights reserved.cells to oocytes through intercellular tight junctions (Gilula et al.,
1978). We reported the ability of thecal cell-derived insulin-like 3
(INSL3) to activate its receptor, leucine-rich repeat-containing G
protein-coupled receptor 8, in the preovulatory oocytes, leading to
decreases in intra-oocyte cAMP levels and subsequent GVBD
(Kawamura et al., 2004). Furthermore, several granulosa cell-
derived epidermal growth factor (EGF)-like ligands (epiregulin,
amphiregulin, and betacellulin) were also found to be important
for GVBD of the preovulatory oocyte by acting at the cumulus cells
(Park et al., 2004).
Endothelin-1 is a 21-amino acid multifunctional peptide. In
addition to its potent vasoconstrictor actions (Levin, 1995), Endothe-
lin-1 is also important in renal, pulmonary, and reproductive
physiology (Boiti et al., 2005; Kon and Badr, 1991; Levin, 1995, 1996;
Meidan and Levy, 2002; Noll et al., 1996; Otani et al., 1996). Using
genome-wide analysis of DNAmicroarray datasets from periovulatory
ovaries, we found major increases in the expression of endothelin-1
and one of its receptors endothelin receptor type A (EDNRA) and
demonstrated the ability of endothelin-1 to promote GVBD of
preovulatory oocytes by using in vitro and in vivo models.
63K. Kawamura et al. / Developmental Biology 327 (2009) 62–70Materials and methods
DNA microarray analyses
Female B6D2F1 mice (n=108) were injected at 21 days of age with
Humegon (7.5 IU per animal, Organon, Oss, Netherlands) to stimulate
follicular growth. Forty-eight hours later, some animals were treated i.
p. with Pregnyl (5 IU per animal, Organon) to induce ovulation. Ovaries
were dissected from animals killed bi-hourly after Humegon treat-
ment (three mice per group) and hourly after Pregnyl treatment (one
mouse per group) for RNA extraction (TRIzol, Invitrogen, Carlsbad,
CA). Aliquots of 6 μg of total RNA at 1 μg/μl for one-chipset
hybridization were stored at −80 °C. Samples were hybridized to the
Affymetrix mouse MGU74v2 arrays A, B, and C according to standard
Affymetrix protocols. The pooled follicular phase samples were
hybridized in duplicate, and the post Pregnyl samples were single
determinations (Kawamura et al., 2005).
Animals
Ovarian samples were obtained from female B6D2F1 mice at 25 days
of age (CLEA Japan, Tokyo, Japan) during treatment with a single i.p.
injection of 7 IU of pregnant mare serum gonadotropin (PMSG)
(Calbiochem, Cambridge, MA) followed at 48 h later with 10 IU of hCG
(ASKA Pharmaceutical, Tokyo, Japan) administrated i.p. to stimulate
follicle maturation and ovulation, respectively. The care and use of
animals was approved by the Animal Research Committee, Akita
University School ofMedicineandStanfordUniversity School ofMedicine.
Real-time RT-PCR
For quantitative real-time RT-PCR, GV stage oocytes, cumulus cells,
and mural granulosa cells were collected from ovaries of PMSG-
treated immature mice at 48 h after treatment (Kawamura et al., 2005,
2004). Cumulus oocyte complexes (COCs) were obtained by punctur-
ing the largest follicles of preovulatory ovaries, and denuded oocytes
were separated from cumulus cells by mechanical pipetting. Granu-
losa cells were obtained separately by puncturing preovulatory
follicles, followed by the removal of COCs.
Quantitative real-time RT-PCR of transcript levels in ovarian cells
and whole ovaries was performed using a SmartCycler (Takara, Tokyo,
Japan) as described (Kawamura et al., 2007, 2005). The primers and
hybridization probes for real-time PCR of endothelin-1, EDNRA,
endothelin receptor type B (EDNRB), endothelin converting enzyme-1
(ECE1), and histone H2a are as follows: endothelin-1: sense 5′-
AGGTTCTTCCAGGTCCAAGC-3′, antisense 5′-GGTGAGCGCACTGACA-
TCTA-3′, probe 5′-6-carboxy-ﬂuorescein (FAM)-CCAATAAGGCC-
ACAGACCAGGC-6-carboxy-tetramethyl-rhodamine (TAMRA)-3′;
EDNRA: sense 5′-GAGGCGTAATGGCTGACAAT-3′, antisense 5′-GTGG-
TGCCCAGAAAGTTGAT-3′, and probe 5′-FAM-CAGCGCTAATCTAA-
GCAGCCACATG-TAMRA-3′; EDNRB: sense 5′-CAGGAAGAA-
GAGCGGTATGC-3′, antisense 5′-CCAACAGAGAGCAAACACGA-3′, probe
5′-FAM-AAGTGGCCAAGACAGTCTTCTGCCT-TAMRA-3′; ECE1: sense 5′-
AAGAACGGAGCTGAGCAGAC-3′, antisense 5′-GGACAGAGCACCAGAC-
CTGT-3′, probe 5′-FAM-CCAGCAACCAGCTCTTCTTCCTAGG-TAMRA-3′;
histone H2a: sense 5′-ACGAGGAGCTCAACAAGCTG-3′, antisense 5′-
TATGGTGGCTCTCCGTCTTC-3′, probe 5′-FAM-AACATCCAGGCCGT-
GCTGCT-TAMRA-3′. To determine the absolute copy number of target
transcripts, cloned plasmid cDNAs for individual gene were used to
generate a calibration curve. Puriﬁed plasmid cDNA templates were
measured, and copy numbers were calculated based on absorbance at
260 nm. A calibration curvewas created by plotting the threshold cycle
against the known copy number for each plasmid template diluted in
log steps from 105 to 101 copies. Each run included standards of diluted
plasmids to generate a calibration curve, a negative control without a
template, and samples with unknown mRNA concentrations.Immunohistochemistry
To localize EDNRA, ovaries were obtained from PMSG-primedmice
before and at 4 h after hCG injection. After ﬁxation with 20% formalin
neutral buffer solution for 24 h at room temperature, tissues were
embedded in parafﬁn and sectioned at 3-μm intervals before
deparafﬁnization and dehydration. Endogenous peroxidase activities
were quenched with 1% periodic acid for 30 min. After blocking with
5% normal goat serum (Dako, Carpinteria, CA) for 30 min slides were
incubated with rabbit anti-EDNRA polyclonal antibodies (NLS4073;
Novus Biologicals, Littleton, CO) at 1:100 dilution overnight at 4 °C and
washed three washes in Tris-buffered saline (TBS). Slides were then
incubated with biotinylated anti-rabbit secondary antibodies (Dako)
for 30min at room temperature. After three washes, bound antibodies
were visualized using a Histostain SP kit (Zymed Laboratories, San
Francisco, CA). For negative controls, the primary antibody was
replaced by nonimmune rabbit IgG (Dako). For antigen blocking
experiments, the primary antibody was adsorbed with 10 μg/ml of the
synthetic immunogen peptide (Novus Biologicals).
Enzyme immunoassay (EIA) and enzyme-linked immunosorbent assay
(ELISA)
For EIA measurement of the endothelin-1 peptide, mouse ovaries
were homogenized in a buffer containing 137 mM NaCl, 20 mM Tris–
HCl, 1% Nonidet P40, 10% glycerol, and a protease inhibitor cocktail
(Roche Applied Science, Indianapolis, IN) before centrifugation at
8000×g for 5 min at 4 °C. The supernatant was removed and stored at
−80 °C until use. After determination of protein levels using the DC
Protein Assay kit (Bio-Rad, Hercules, CA), samples were adjusted to
1 M acetic acid–20 mM HCl and then acetone was added to a ﬁnal
concentration of 66%. Precipitated proteins were removed by
centrifugation for 30 min at 3000×g. The extracted peptide fractions
were lyophilized using a lyophilizer (Labconco, Kansas City, MO).
Levels of endothelin-1 in reconstituted samples were quantiﬁed using
the EIA kit for endothelin-1 (Peninsula laboratories, San Carlos, CA)
according to the manufacturer's instructions. The results were
normalized by protein concentrations and expressed as μg of
endothelin-1 per mg protein.
To measure phosphorylation of extracellularly regulated kinase 1/2
(ERK1/2) in COCs, preovulatory follicles were treated with or without
100 ng/ml endothelin-1 or 1 μg/ml hCG in Leibovitz's L-15 medium
without fetal bovine serum (FBS) for 0.5,1, 2, and 4 h. After culture, COCs
were isolated, and proteins from 30 COCs were extracted in a buffer
containing 150 mM NaCl, 20 mM Tris–HCl, 1 mM ethylene diamine
tetraacetate, 1 mM ethylene glycol-bis (2-aminoethyl)-N, N,N′,N′-
tetraacetic acid, 1% Triton-X 100, 2.5 mM sodium pyrophosphate,
1mMβ-glycerophosphate,1mMNa3VO4, and 1 μg/ml leupeptin, before
centrifugation at 8000×g for 10 min at 4°C. The supernatant was
removed and stored at −80 °C until use. Levels of phosphorylated and
total ERK1/2 in the same sample were quantiﬁed using the PathScan
Phospho-p44/42 MAPK Sandwich ELISA kit (Cell Signaling Technology,
Beverly, MA) and ERK1/2 ELISA kit (Calbiochem, Cambridge, MA)
according to the manufacturer's instructions, respectively. The levels of
phosphorylated ERK1/2 were normalized to total ERK1/2 levels.
Evaluation of GVBD
Preovulatory follicles were excised from mouse ovaries at 48 h
after PMSG treatment and cultured to examine GVBD of oocytes
(Kawamura et al., 2004; Tsafriri et al., 1996). Follicles (20–30 per vial)
were treated with or without endothelin-1 (AnaSpec, San Jose, CA),
Sarafotoxin S6c (Alexis Biochemicals, San Diego, CA) or 1 μg/ml hCG
(American Pharmaceutical Partners, Inc., Schaumburg, IL) in Leibo-
vitz's L-15 medium (Invitrogen) without FBS. Some follicles were also
treated with 100 ng/ml endothelin-1 with or without BQ-123 (Alexis
Fig. 1. Gonadotropin stimulation of endothelin-1 (EDN1) and EDNRA expression in
mouse ovaries. Gonadotropin regulation of EDN1 (A), EDNRA (B), EDNRB (C), and ECE1
(D) transcripts in ovaries. Line graphs represent DNA microarray data depicting the
expression intensity of each transcript (right y axis), whereas bar graphs depict
quantitative real-time RT-PCR results (left y axis; mean±SEM, n=4). Values for
expression intensity were derived from integration of hybridization signals from
multiple probe sets for individual genes. ⁎, Pb0.05 vs. 48 h of PMSG treatment. (E) hCG
stimulation of endothelin-1 peptide levels in ovaries of PMSG-primed mice. Ovarian
content of endothelin-1 (μg/mg ovarianwet weight) was measured by EIA (mean±SEM,
n=4). ⁎, Pb0.05 vs. 0 h of hCG treatment.
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MO) or U0124 (Sigma), pertussis toxin (Sigma) or treated with hCG
with or without BQ-123 or BQ-788. The vials were ﬂushed at the start
of the culture with O2/N2 (at a 1: 1 ratio), sealed, and cultured at 37 °C
with gentle shaking for 8 h. After culture, COCs were isolated, and,
after cumulus cell removal, oocytes were examined for the occurrence
of GVBD under a Hoffman modulation contrast microscopy (Nikon
Inc., Tokyo, Japan). To examine the role of cumulus cells in the
endothelin-1-induced GVBD of oocytes, COCs were obtained by
puncturing the largest follicles from preovulatory ovaries, whereas
denuded oocytes were separated from cumulus cells by mechanical
pipetting. These cells were cultured in minimum essential media
(MEM, Invitrogen) without FBS in the presence of 4 mM hypoxanthine
(Sigma) with or without 10 ng/ml endothelin-1 for 16 h at 37 °C in 5%
CO2/95% air. Some COCs were also treated with 10 ng/ml endothelin-1
or with 1 μg/ml recombinant follicle-stimulating hormone (FSH)
(11,468 IU/mg, Organon) with or without BQ-123 or BQ-788. The dose
of FSH was chosen based on previous studies (Park et al., 2004). After
culture, the occurrence of GVBD was examined.
In vivo analyses of GVBD
To study the effect of endothelin-1 treatment on oocytematuration
in vivo, intrabursal injection was performed (Kawamura et al., 2004).
B6D2F1 mice at 9 weeks of age at the diestrous stage were primed
with PMSG (7 IU) and, at 48 h later, lightly anesthetized. One of the
ovaries was exteriorized through a small lumbosacral incision.
Endothelin-1 [1 or 5 μg per 10 μl of phosphate-buffered saline (PBS)]
was injected through a 30-gauge needle threaded into the ovarian
bursa via the adjoining fat pad under stereomicroscope (MZ16, Leica,
Wetzlar, Germany). The contralateral ovaries were injected with PBS
alone and served as negative controls. After injection, the ovary was
returned to the abdominal cavity and skin was clipped. After 12 h of
treatment, COCs were collected by puncturing the largest ovarian
follicles to examine the occurrence of GVBD in oocytes. For positive
control, hCG (10 IU) was administrated by i.p. injection and oocytes
were retrieved from the oviducts.
Evaluation of ﬁrst polar body extrusion
For evaluating the transition frommetaphase I (MI) tometaphase II
(MII) stage oocytes (Kawamura et al., 2005), COCs were obtained from
B6D2F1 mouse ovaries at 48 h after PMSG treatment as described
above. COCs were washed twice, transferred to MEM supplemented
with Earle's salts, 10 μg/ml streptomycin sulfate, 75 μg/ml penicillin G
without FBS, and cultured with or without endothelin-1 for 24 h at
37 °C in 5% CO2/95% air. For positive controls, COCs were treated with
3 ng/ml brain-derived neurotrophic factor (BDNF) (Kawamura et al.,
2005). The occurrence of ﬁrst polar body extrusion in the oocyte was
examined after removing cumulus cells by using a small-bore pipette
under the Hoffman modulation contrast microscopy.
In vitro maturation, fertilization, and early embryonic development
We performed in vitro maturation of oocytes followed by in vitro
fertilization as described (Kawamura et al., 2005). COCs from PMSG-
primed B6D2F1 mice were obtained in M2 medium (Sigma)
supplemented with 0.1% FBS before culturing in MEM supplemented
with Earle's salts, 10 μg/ml streptomycin sulfate, 75 μg/ml penicillin G,
and 0.1% fetal bovine serumwith or without 10 ng/ml endothelin-1 or
3 ng/ml BDNF at 37 °C in 5% CO2/95% air. After 16 h of treatment,
cumulus cells were removed and the oocytes were examined and
classiﬁed according to their developmental stages (GV, MI, or MII). MII
oocytes were inseminated with sperm from B6D2F1 males and
incubated for 6 h at 37 °C in 5% CO2/95% air. After in vitro fertilization,
fertilized oocytes were recovered, washed twice, and cultured inhuman tubal ﬂuid medium (Chemicon, Temecula, CA). Twenty-two
hours after insemination, two-cell-stage embryos were collected and
cultured in 50 μl drops of KSOM medium for 5 more days up to the
blastocyst stage. Embryonic development was monitored daily under
the Hoffman modulation contrast microscopy, and the progression of
fertilized eggs to preimplantation embryos was assessed.
Statistical analysis
Statistical analysis was carried out by using Mann–Whitney U test
for paired comparison and the one-way analysis of variance followed
65K. Kawamura et al. / Developmental Biology 327 (2009) 62–70by Fisher's protected least signiﬁcant difference for multiple group
comparison. Results are presented as mean±SEM of at least three
separate experiments.
Results
Gonadotropin stimulation of endothelin-1 and EDNRA expressions in
preovulatory ovaries
We used DNA microarray analyses to identify ovarian paracrine
ligands induced by the LH surge during the preovulatory period.
Immature mice were treated with Humegon (containing FSH and LH
activities) and Pregnyl (containing LH/hCG activity) to stimulate
follicular maturation and ovulation, respectively. As shown in Fig. 1A
(line graph), the expression of endothelin-1 mRNA was decreased
following treatment with Humegon but treatment with Pregnyl
increased endothelin-1 transcript levels, showing a peak at 2 h,
followed by a decline. Furthermore, transcript levels for the
endothelin-1 receptor, EDNRA were also increased after treatment
with Pregnyl (Fig. 1B, line graph), whereas transcript levels for the
other endothelin-1 receptor, EDNRB showed minor changes (Fig. 1C,
line graph). Although ECE1, known to be essential for endothelinFig. 2. Localization of EDN1 and EDNRA in mouse ovaries and their stimulation by hCG in
expression in mouse oocytes (OC), cumulus cells (CC), and mural granulosa cells (GC). Transc
PCR before and 2 h after hCG treatment (mean±SEM). Five samples prepared from individu
detection of EDNRA in ovaries of PMSG-primed mice 4 h after hCG injection (C, insert: high m
found in cumulus (arrow) and mural granulosa (arrowhead) cells of preovulatory follicles (w
nonimmune IgG and serve as controls. (Scale bars, 100 μm.)biosynthesis (Schmidt et al., 1994), was expressed throughout the
experimental period, treatment with gonadotropins did not regulate
its levels (Fig. 1D, line graph). To conﬁrm DNA microarray data, we
further performed real-time RT-PCR of ovarian transcripts for these
genes in mice treated with PMSG followed by an ovulatory dose of
hCG 48 h later (Figs. 1A–D, bar graphs). Similar stimulation of
endothelin-1 and EDNRA transcript levels were observed. In addition
to demonstrating preovulatory increases in both endothelin-1 and
EDNRA transcripts in whole ovaries (Figs. 1A and B), the hCG
stimulation of ovarian endothelin-1 peptide levels was detected
using EIA (Fig. 1E). Treatment with hCG increased ovarian endothelin-
1 antigen levels by N2-fold within 2 h after hormonal treatment,
followed by a decline at 8 h.
Localization of endothelin-1 and EDNRA in the ovary and their
stimulation by hCG in cumulus and granulosa cells
Using isolated ovarian cells, we examined cell types expressing
endothelin-1 and EDNRA in the mouse ovary and the regulation of
endothelin-1 and EDNRA transcript levels by hCG treatment based on
real-time RT-PCR. As shown in Fig. 2A, the endothelin-1 mRNA was
expressed in all cell types tested. In addition, treatment with hCGcumulus and granulosa cells. Effects of hCG treatment on EDN1 (A) and EDNRA (B)
ript levels of EDN1 and EDNRA in isolated ovarian cells were quantiﬁed by real-time RT-
al animals were used. ⁎, Pb0.05 vs. 0 h of hCG treatment. (C–E) Immunohistochemical
agniﬁcation) and ovaries of PMSG-primed mice before hCG treatment (D). EDNRAwas
hite arrowheads). EDNRA staining was increased by hCG treatment. (E) Sections with
Fig. 3. EDN1 stimulation of meiosis resumption of preovulatory oocytes. (A) In vitro effects of EDN1 on GVBD of oocytes. Preovulatory follicles were cultured without (control, C) or with
hCG (1 μg/ml) or different doses of EDN1 for 8 h before evaluation of oocytes undergoing GVBD (n=3, 38–53 follicles per group). ⁎, Pb0.05 vs. control. (B) In vivo induction of GVBD after
EDN1 treatment.Mice at 2 days after PMSGprimingwere treatedwithEDN1 (1or 5 μgper10 μl of PBS) via intrabursal injections (treatment, T) orhCG (10 IU)via i.p. injections. After12h of
treatment, oocyteswere retrieved by puncturing of the ovaries to release COCs for assessingmorphology (n=4 animals, 33–37 oocytes per group). The contralateral ovarieswere injected
with PBS alone and served as negative controls (non-treatment, NT). Some PMSG-primed animals were treated with hCG (10 IU) via i.p. injections and oocytes were retrieved from the
oviducts. ⁎, Pb0.05vs. non-treatment. (C) Effects of the selective EDNRBagonist, SarafotoxinS6c (SFXS6c) onGVBDof oocytes and antagonistic effects of theEDNRAantagonist, BQ-123on
EDN1 stimulationofGVBD. Preovulatory follicleswere culturedwithorwithoutdifferent dosesof SFX S6c, orwith EDN1 (100ng/ml)with orwithoutBQ-123or theEDNRBantagonist, BQ-
788 (n≥3, 38–80 follicles per experimental group). ⁎, Pb0.05 vs. control or EDN1 alone groups. (D) Partial suppression of the hCG induction of GVBD in cultured preovulatory follicles by
the EDNRA antagonist. Preovulatory follicles were cultured with hCG (0.1 or 0.3 μg/ml) with or without different concentrations of BQ-123 or BQ-788 (n≥4, 43–130 follicles per
experimental group). ⁎, Pb0.05 vs. hCG alone groups. (E) Involvement of the MAPK/ERK pathway in the EDN1 stimulation of GVBD. Preovulatory follicles were cultured with EDN1
(100 ng/ml) with or without different doses of the MEK1/2 inhibitor, U0126 or its inactive analog, U0124 (30 μM). After culture, COCs were isolated and examined for the occurrence of
GVBD (n=3, 42–60 follicles per group). ⁎, Pb0.05 vs. EDN1 alone groups. (F) Time course of EDN1 induction of ERK1/2 phosphorylation in COCs of preovulatory follicles. Preovulatory
follicleswere culturedwith EDN1 (100 ng/ml) or hCG (1 μg/ml). After culture, COCswere isolated and ELISAwas performed tomeasure levels of phosphorylated and total ERK1/2 (n=3, 30
COCs per group). Results are presented as the ratio of phosphorylated to total ERK1/2. ⁎, Pb0.05 vs. 0 h treatment groups. (G) Lack of involvement of the inhibitory G proteins in the EDN1
stimulation of GVBD. Preovulatory follicleswere culturedwithout (controls, C) orwith EDN1 (100 ng/ml) or INSL3 (100 nM) in thepresence or absence of different doses of pertussis toxin
(PT) capable of blocking Gi actions. After culture, COCs were isolated and examined for the occurrence of GVBD (n=3, 42–57 follicles per group). ⁎, Pb0.05 vs. INSL3.
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and mural granulosa cells (N22-fold), but not in oocytes (Fig. 2A).
Although a clear stimulation of EDNRA transcripts was found in
cumulus and mural granulosa cells, levels of this transcript were
negligible in oocytes (Fig. 2B). The cell types expressing EDNRA
protein in preovulatory ovaries were further determined by using
immunohistochemistry. EDNRA staining was found in cumulus and
mural granulosa cells of preovulatory follicles at 4 h after hCG
treatment (Fig. 2C). Although weak signals were found in granulosa
cells of preovulatory follicles in PMSG-primed ovaries before hCG
treatment (Fig. 2D), their expressions were increased by hCG
treatment (Fig. 2C). Although oocytes were also stained with the
EDNRA antibody (Figs. 2C and D), the signals were still present after
antigen blocking, suggesting non-speciﬁc EDNRA signals in oocytes
(data not shown).Fig. 4. EDN1 stimulation of GVBD by cultured COCs. (A) Effects of EDN1 treatment on GVBD
preovulatory follicles were cultured in the presence of hypoxanthine (4 mM) without (con
determined (n≥4, 67–150 oocytes per group). ⁎, Pb0.05 vs. control. (B) Antagonistic effects o
EDN1 (10 ng/ml) with or without BQ-123 or BQ-788 in the presence of hypoxanthine (4 mM)
D) FSH stimulation of EDN1 and EDNRAmRNA levels by cumulus cells. COCs were cultured w
and EDNRA (D) transcript levels by real-time RT-PCR (mean±SEM, n=3). Three samples in
suppression of the FSH induction of GVBD in cultured COCs by BQ-123. COCs were cultu
experimental group). ⁎, Pb0.05 vs. FSH alone groups.Endothelin-1 stimulation of meiosis resumption of preovulatory oocytes
Based on the hCG stimulation of endothelin-1 and EDNRA
expression, we tested if endothelin-1 acts as a paracrine factor to
regulate oocyte functions. In cultured preovulatory follicles, treatment
with endothelin-1, like hCG, induced GVBD in oocytes in a dose-
dependent manner (Fig. 3A). To test endothelin-1 actions in vivo, local
intrabursal administration of endothelin-1 was performed in the
diestrous mice primed with PMSG for 48 h. As shown in Fig. 3B, a
dose-dependent induction of oocyte maturationwas evident based on
percentages of oocytes undergoing GVBD found in treated ovaries as
compared with the contralateral untreated ovaries. In contrast, i.p.
treatment with hCG induced GVBD in 95% of oocytes retrieved from
the oviducts (Fig. 3B). Unlike hCG, treatment with endothelin-1 alone
did not lead to follicle rupture (data not shown).by cultured denuded oocytes (DOs) and COCs. Denuded oocytes or COCs isolated from
trols, C) or with EDN1 (10 ng/ml) for 16 h. After culture, the proportion of GVBD was
f BQ-123 on the EDN1 stimulation of GVBD by cultured COCs. COCs were cultured with
(n≥4, 45–101 follicles per experimental group). ⁎, Pb0.05 vs. EDN1 alone groups. (C and
ithout (control) or with FSH (1 μg/ml) for 2, 4, and 6 h before quantiﬁcation of EDN1 (C)
each time point prepared from 10 COCs were used. ⁎, Pb0.05 vs. control. (E) Partial
red with FSH (1 μg/ml) with or without BQ-123 or BQ-788 (n≥4, 42–69 oocytes per
68 K. Kawamura et al. / Developmental Biology 327 (2009) 62–70Endothelin-1 binds both EDNRA and EDNRB (Arai et al., 1990;
Sakurai et al., 1990). Although no EDNRA agonist is available,
treatment of cultured preovulatory follicles with a selective EDNRB
agonist, Sarafotoxin S6c (Williams et al., 1991) did not induce GVBD
(Fig. 3C). Of interest, the stimulatory effect of endothelin-1 on GVBD
was blocked by cotreatment with an EDNRA antagonist, BQ-123
(Douglas et al., 1994), but not an EDNRB antagonist, BQ-788 (Ishikawa
et al., 1994) (Fig. 3C). In contrast, treatment with these antagonists
alone was ineffective (Fig. 3C). These data suggest that the ability of
endothelin-1 to induce GVBD is mediated through EDNRA. Unlike
hCG, treatment with endothelin-1 did not induce cumulus cell
expansion (data not shown). Using the EDNRA antagonist, we further
examined whether the suppression of endothelin-1/EDNRA signaling
inhibits hCG-induced GVBD in oocytes of cultured preovulatory
follicles. As shown in Fig. 3D, cotreatment with the EDNRA antagonist,
BQ-123 blocked by the hCG stimulation of GVBD in a dose-dependent
manner. At 0.1 and 0.3 μg/ml of hCG, the antagonist at 30 ng/ml
suppressed the hCG actions by 36 and 38%, respectively (Fig. 3D). We
further analyzed the roles of the mitogen-activated protein kinase
(MAPK)/ERK signaling pathway as downstream mediators of the
endothelin-1/EDNRA-induced GVBD. The ability of endothelin-1 to
stimulate GVBD was suppressed by cotreatment with a mitogen-
activated protein kinase kinases 1/2 (MEK1/2) inhibitor, U0126, but
not with its inactive analog, U0124 in a dose-dependent manner (Fig.
3E). Phosphorylation of ERK1/2 in COCs was induced by treatment
with either endothelin-1 or hCGwithin 30min, with peak levels found
at 2 h after culture (Fig. 3F), consistent with previous studies showing
ERK1/2 phosphorylation in cumulus cells after hCG stimulation (Su et
al., 2002). Because EDNRA belongs to the seven-transmembrane G-
coupled receptor superfamily, we examined possible involvement of
the inhibitory G proteins to decrease cellular cAMP levels during
endothelin-1 induction of GVBD in oocytes. Pretreatment with an
inhibitor of inhibitory G protein, pertussis toxin, did not affect
endothelin-1 actions but was effective in blocking the INSL3
stimulation of GVBD (Fig. 3G), consistent with an earlier report
(Kawamura et al., 2004).
Due to the expression of EDNRA transcripts in cumulus cells, but
not in oocytes, we assessed the importance of cumulus cells in
mediating endothelin-1 actions using cultured COCs and denuded
oocytes. Because oocytes obtained from preovulatory follicles under-
went spontaneous GVBD, we cultured COCs and denuded oocytes in
the presence of hypoxanthine to inhibit the spontaneous GVBD. In
cumulus-enclosed oocytes, treatment with endothelin-1 overcame
the inhibitory effect of hypoxanthine on oocyte GVBD; however,Fig. 5. Lack of effects of EDN1 on the extrusion of ﬁrst polar body and cytoplasmic maturatio
cultured COCs. COCs isolated from preovulatory follicles were culturedwithout (controls, C) o
ﬁrst polar body extrusion was determined (n≥3, 47–150 oocytes per group). (B) Effect of ED
COCs obtained from preovulatory follicles were cultured without (control) or with EDN1 (1
inseminated and cultured for 5 more days without hormones. The percentage of MII oocytes
oocytes per group).similar treatment was ineffective in denuded oocytes (Fig. 4A). In the
COCs model, the stimulatory effect of endothelin-1 on GVBD was also
blocked by cotreatment with the EDNRA antagonist, BQ-123 but not
the EDNRB antagonist, BQ-788 (Fig. 4B). Because COCs express few or
no LH receptors in mice (Wang and Greenwald, 1993), COCs were
treated with FSH to induce GVBD. Treatment with FSH increased
transcript levels of both endothelin-1 and EDNRA in COCs (Figs. 4C and
D), although the levels of endothelin-1 and EDNRA in the ovary at 2 h
after PMSG treatment were unchanged (Figs. 1A–D). Because the
present in vitro FSH treatment was performed using COCs obtained
from preovulatory follicles at 48 h after PMSG priming whereas
ovaries used in the DNA microarray were obtained from ovaries of
immature mice with no preovulatory follicles, these two ﬁndings
cannot be directly compared. Similar to the partial suppression of
hCG-induced GVBD of oocytes in cultured preovulatory follicles by the
EDNRA antagonist, BQ-123, cotreatment with BQ-123 blocked by 32%
the FSH stimulation of GVBD in COCs (Fig. 4E).
Lack of effects of endothelin-1 on the extrusion of ﬁrst polar body and
cytoplasmic maturation of preovulatory oocytes
We further tested the ability of endothelin-1 to promote further
development of oocytes. Because oocytes showed high spontaneous
maturation rates (N80%) when COCs were cultured in serum-contain-
ing media (data not shown), we used a low concentration of serum
(0.1% FBS) to minimize effects of uncharacterized serum factors on
oocyte maturation (Kawamura et al., 2005, 2008). Treatment of COCs
with endothelin-1, unlike BDNF, did not affect the transition of oocytes
fromMI toMII stage of development (Fig. 5A). The role of endothelin-1
in conditioning the oocytes for subsequent fertilization and progres-
sion to blastocysts was also evaluated in vitro (Fig. 5B). COCs obtained
from mice primed for 48 h with PMSG were cultured with or without
endothelin-1. To avoid hardening of the zona pellucida that is
unfavorable for in vitro fertilization, 0.1% FBS was included for all
cultures. These MII oocytes were then fertilized in vitro without
further treatment with endothelin-1. As shown in Fig. 5B, pretreat-
mentwith endothelin-1, unlike BDNF, did not increase the proportions
of MII oocytes that developed into the two-cell or blastocyst-stage
embryos.
Discussion
The present data suggested that endothelin-1 is a novel paracrine
factor secreted by ovarian somatic cells of preovulatory follicles ton of preovulatory oocytes. (A) Effects of EDN1 treatment on ﬁrst polar body extrusion by
r with EDN1 or BDNF (3 ng/ml) for 24 h. After culture, the percentage of oocytes showing
N1 in the conditioning of oocytes for the development into preimplantation embryos.
0 ng/ml) or BDNF (3 ng/ml) for 16 h. After progression into the MII stage, oocytes were
developing into 2-cell-stage or blastocyst-stage embryos were evaluated (n≥3, 102–168
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GVBD in cultured COCs but not denuded oocytes, endothelin-1 likely
acts on cumulus cells to regulate the communication between
cumulus cells and oocytes. Since only INSL3 (Kawamura et al., 2004)
and EGF-like ligands (Park et al., 2004) have been found as ovarian
paracrine factors induced by the preovulatory LH surge and capable of
promoting GVBD, the present ﬁndings of a potent action of
endothelin-1 in the nuclear maturation of the oocyte provide another
intraovarian mechanism underlying meiotic resumption.
Endothelin-1 belongs to a structurally homologous peptide family
that includes endothelin-2 and endothelin-3. Endothelin peptides
bind two G protein-coupled receptors, EDNRA and EDNRB. The EDNRA
receptor has a high speciﬁcity for endothelin-1 (endothelin-
1Nendothelin-2Nendothelin-3), whereas EDNRB binds all three
ligands with similar afﬁnity (Arai et al., 1990; Sakurai et al., 1990).
The present use of speciﬁc antagonists and agonists for these
receptors indicated the essential role of EDNRA in mediating
endothelin-1 actions. The importance of the endothelin-1/EDNRA
signaling system in meiosis resumption could not be investigated in
endothelin-1 or EDNRA null mice, because these animals die shortly
after birth (Clouthier et al., 1998; Kurihara et al., 1994). It is interesting
to note that increases in endothelin-1 transcripts and proteins were
evident within 2 h after hCG treatment, before the induction of GVBD
that was usually found at 4–5 h after hCG treatment in the present
model. In contrast, a major increase in endothelin-2 levels was found
only at 12 h after hCG treatment in the preovulatory rat ovary and
endothelin-2 has been found as a paracrine factor important for
follicle rupture by disrupting somatic cell organization which takes
place at 12–14 h after hCG administration (Ko et al., 2006). Because
endothelin-1 induces meiotic resumption through the EDNRA and
endothelin-2 regulates follicle rupture by acting through EDNRB
(Palanisamy et al., 2006), it is apparent that the two endothelin
peptides regulate different ovulation-related processes in a receptor-,
time- and cell type-speciﬁc manner.
Our data demonstrates that endothelin-1, like EGF-like ligands (Park
et al., 2004), acts through cumulus cells to regulate oocyte maturation,
whereas INSL3 directly suppresses intra-oocyte cAMP levels (Kawa-
mura et al., 2004). The cellularmechanismsunderlying cumulus-oocyte
communication duringmeiotic resumption are only partially known. It
is possible that, after the LH surge, an inhibitory inﬂuence of the
follicular environment is decreased. This could occur as a consequence
of the breakdown ingap junction communication between the cumulus
cells and oocytes (Gilula et al., 1978), leading to the interruption of the
transfer of inhibitorymolecules (such as cAMP) to the oocyte. But a role
for positive stimuli has also been suggested (Kawamura et al., 2004;
Park et al., 2004). Following gonadotropin stimulation, overriding
signals, such as endothelin-1 or EGF-like ligands, could be induced in
cumulus or granulosa cells to promote the nuclear maturation of
oocytes. It is becoming clear that a combination of both inhibitory and
stimulatory factors plays redundant roles to insure the prolonged
meiotic arrest before ovulation and the successful oocyte maturation
during the ovulatory process induced by the LH surge.
It is believed that intra-oocyte cAMP is critical in the control of
meiosis progression, with high levels of cAMP inhibiting the
resumption of meiosis (Eppig and Downs, 1984). Intra-oocyte cAMP
may be produced either endogenously (Horner et al., 2003) or
transferred to the oocyte via gap junctions by surrounding somatic
cells (Dekel et al., 1981). Also, purines present in the follicular ﬂuid,
such as hypoxanthine, are believed to contribute to the meiotic block
by causing accumulation of cAMP within the oocyte through the
repression of cAMP phosphodiesterase activity (Downs et al., 1985,
1989). Although the preovulatory LH surge has been proposed to
disrupt the transfer of cAMP from cumulus cells to oocytes (Dekel et
al., 1981), intra-oocyte cAMP levels in the present COC model are
maintained in the presence of hypoxanthine.We found that treatment
with endothelin-1, similar to FSH (Eppig and Downs, 1987), overcamethe inhibitory effect of hypoxanthine on oocyte GVBD in cultured COC.
However, unlike INSL3 (Kawamura et al., 2004), endothelin-1
stimulation of oocyte GVBD is not mediated by the inhibitory G
proteins. Because our data showed that endothelin-1 acts on cumulus
cells to indirectly regulate oocyte GVBD, these results suggest that the
stimulatory effect of endothelin-1 on oocyte GVBD is not mediated by
G proteins in cumulus cells. Accumulating evidences indicate that
activation of MAPK in cumulus cells, but not oocytes, is important for
gonadotropin-induced meiotic resumption in mammals (Liang et al.,
2007). We also found the involvement of the MAPK pathway in the
endothelin-1 mediation of oocyte maturation. Gonadotropin regula-
tion of oocyte GVBD has been attributed to the breakdown of gap
junctions between cumulus cells and oocyte (Dekel et al., 1981),
increases in oocyte phosphodiesterase activity by hypoxanthine and/
or the secondary actions of uncharacterized inductive factors released
by cumulus cells. Future studies are required to determine the exact
mechanisms underlying endothelin-1 induced GVBD.
The important roles of ovarian paracrine factors in the regulation of
oocyte functions are becoming clear. Genome-wide analyses based on
our DNA microarray datasets indicated that a limited number of
ligands are induced by the preovulatory LH surge to promote oocyte
maturation. In addition to endothelin-1, EGF-like ligands (Park et al.,
2004) and INSL3 (Kawamura et al., 2004) were found to mediate the
actions of LH in controlling GVBD of the oocyte. Although no study is
available regarding the ability of EGF ligands to directly induce GVBD
in vivo, intrabursal treatment with endothelin-1 and INSL3 (Kawa-
mura et al., 2004) induced premature oocyte maturation without the
LH surge. Elucidation of the potentially overlaying mechanisms
underlying these ovarian paracrine signaling systems could provide
better strategies for in vitro maturation of oocytes and allow the
formulation of new contraceptive strategies.
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